semaglutide drug mounjaro Lilly's leads to more and faster weight loss than Novo obesity drug, data analysis finds Switching Semaglutide to Tirzepatide |

These were two well-designed trials, with the STEP 1 trial consisting of almost 2,000 obese individuals without diabetes and the STEP 4 trial consisting of about 900 obese individuals without diabetes

See what the 10-year data suggests.) As always, you should discuss your risk for the development of thyroid cancer with your provider before beginning GLP-1 medications and determine if the benefits of taking the medication outway your specific risk level

Xu X, Lin L, Chen P, Yu Y, Chen S, Chen X, et al

But when combined with stimulant-class peptides or compounds affecting catecholamine signalling, cardiovascular events spiked sharply

We'd love to hear your feedback and answer any questions you have

Heisel, A